Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 1990British Journal of Clinical PharmacologyOpen Access

Relationship between mephenytoin oxidation polymorphism and phenytoin, methylphenytoin and phenobarbitone hydroxylation assessed in a phenotyped panel of healthy subjects.

View Full Paper
Ask AI
Bookmark
Share

Authors

JSJ.H.M. SchellensLeiden UniversityJWJH van der WartLeiden UniversityDBDD BreimerLeiden University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Schellens et al. (1990) studied this question.

synapsesocial.com/papers/6a6fb61ba7fbea1e4407d3e1https://doi.org/10.1111/j.1365-2125.1990.tb03687.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sparteine oxidation by the human liver: Absence of inhibition by mephenytoin1984 · 19 citations
  2. 2Researches on Substituted 5-Phenylhydantoins11954 · 29 citations
  3. 3Importance of genetic factors in the regulation of diazepam metabolism: Relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotype1989 · 252 citations
  4. 4Polymorphic metabolism of mephenytoin in man: Pharmacokinetic interaction with a co-regulated substrate, mephobarbital1986 · 50 citations